SlideShare a Scribd company logo
EpilepsyEpilepsy
 An estimated 40 million individuals
worldwide have epilepsy.
 This estimate is based on epidemiological
data gathered as part of the Global Burden
of Disease (GBD)
Epidemiology
 Mortality data from GBD, a traditional
measure of burden of disease, indicates
that 142,000 persons with epilepsy die
annually, equating to 0.2% of all deaths
worldwide.
Epidemiology
 Acknowledging the need to define burden
beyond mortality, the GBD study
introduced a new measure of burden of
diseases, injuries, and risk factors, the
DALY (disability adjusted life year).
Epidemiology
 One DALY equates to 1 year of healthy
life lost due to disability or poor health.
Epilepsy is estimated to contribute
7,854,000 DALYs (0.5%) to the global
burden of disease.
Epidemiology
 A clear pattern emerges from the GBD
data whereby over half of all deaths and
half of all years of healthy life lost to
epilepsy occur in low-income countries.
Epidemiology
 Moreover, almost one in five of all deaths
and almost one in four of all years of
healthy life lost to epilepsy worldwide
occur among children living in low-income
countries.
Epidemiology
 A major contributor in low-income
countries is the “treatment gap,” that is, the
difference between the number of
individuals with active epilepsy and the
number who are being appropriately
treated at a given point in time.
Epidemiology
 Estimates suggest that up to 90% of people
with epilepsy in resource-poor countries
are inadequately treated .
Epidemiology
 The burden of epilepsy, however, extends
beyond physical health status. Stigma and
discrimination are common features of the
condition worldwide.
Epidemiology
 Profound social isolation, feeling of shame
and discomfort, and higher risk of
psychiatric disorder are among a host of
variables contributing to a compromised
quality of life.
DEFINITIONS
DEFINITIONS
 A seizure is a paroxysmal event due to
abnormal, excessive, hypersynchronous
discharges from an aggregate of central
nervous system (CNS)neurons (cortical
neurons).
 Have various manifestations.
DEFINITIONS
 A seizure that occurs in the absence of an
acute provoking event is considered
unprovoked
 An acute provoked seizure is one that
occurs in the context of an acute brain
insult or systemic disorder, such as, but not
limited to, stroke, head trauma, a toxic or
metabolic insult, or an intracranial
infection
DEFINITIONS
Epileptic seizure:
Is a “transient occurrence of signs and/or
symptoms due to abnormal excessive or
synchronous neuronal activity in the brain”.
DEFINITIONS
Epileptic seizures must be distinguished from
nonepileptic seizures and from other
conditions that may produce clinical
manifestations that are highly similar to
those caused by epileptic seizures.
DEFINITIONS
Epilepsy :
(recurrent, unprovoked seizures) individual
have at least two unprovoked seizures on
separate days, generally 24 hours apart.
DEFINITIONS
 An individual with a single unprovoked
seizure or with two or more unprovoked
seizures within a 24-hour period is
typically not at that time considered to
have met the criteria for labeling him with
the diagnosis of epilepsy per se
Epilepsy Syndromes
Epilepsy, like cancer, is not a single disorder,
and the efforts to identify specific forms of
epilepsy reflect the importance of the
diversity within the epilepsies.
Epilepsy Syndromes
The epilepsy syndromes represent forms of
epilepsy that have different causes, different
manifestations, different implications for
short- and long-term management and
treatment, and different outcomes
PATHOPHYSIOLOGY
PATHOPHYSIOLOGY
Those questions were as follows:
(i)what are the long-term consequences of
seizures? Can these be modified?
(ii)what is the best anticonvulsant therapy?
(iii) What is the best antiepileptogenic
therapy?
PATHOPHYSIOLOGY
 From these questions, the mechanisms of
seizure initiation, prolongation, and
termination must be addressed, and their
sequelae defined.
 Further, the mechanisms underlying the
development of spontaneous repetitive
seizures (SRS) (epileptogenesis) and
associated cognitive dysfunction must
begin to be addressed.
PATHOPHYSIOLOGY
Focal-Onset Seizures
 The following mechanisms may coexist in
different combinations to cause focal-onset
seizures:
1- Increased activation
2- Decreased inhibition
3-Defective activation of (GABA) neurons
Increased activation
PATHOPHYSIOLOGY
Beginning with receptor activation, followed
by alterations in membrane polarization,
potentially loops around to result in
alterations of the properties of the initial
trigger of receptor activation.
PATHOPHYSIOLOGY
Such a loop likely underlies normal plasticity
associated with processes like learning and
memory, but perhaps becomes unstable with
seizures and epileptogenesis, leading to
aberrant plasticity that could result in both
seizures and cognitive dysfunction
PATHOPHYSIOLOGY
Glutamatergic Ion Channels
 Glutamate is the major excitatory
neurotransmitter in the brain.
 The release of glutamate causes an EPSP
in the postsynaptic neuron by activating
the families of glutamate-activated ligand-
gated cation channels.
Glutamatergic Ion Channels
 classified according to their preferred
agonists:
1- kainate, -amino-3-hydroxy-5-methyl-4-
isoxazole propionate (AMPA) = (GluR1-4)
and (GluR5-7)
2- N-methyl-D-aspartate (NMDA) = (NR1,
NR2A-D)
Glutamatergic Ion Channels
 Calcium influx through NRs is thought to
mediate the calcium-activated processes
involved in long-term potentiation and
depression (LTP and LTD) which are
thought to be synaptic models of learning
and memory .
 They participate in the induction of
plasticity in this fashion.
Neural Plasticity
Neural Plasticity
 The capacity of the nervous system to
change—generally referred to as neural
plasticity
 plasticity is so fundamental that its
essential cellular and molecular
underpinnings are likely to be conserved in
the nervous systems of very different
organisms.
Epilepsy & Neural Plasticity
It seems likely that abnormal activity
generates plastic changes in cortical circuitry
that are critical to the pathogenesis of the
disease.
The importance of neuronal plasticity in
epilepsy is indicated most clearly by an
animal model of seizure production called
kindling.
Epilepsy & Neural Plasticity
 To induce kindling, a stimulating electrode
is implanted in the brain, often in the
amygdala (a component of the limbic
system that makes and receives
connections with the cortex, thalamus, and
other limbic structures, including the
hippocampus).
Epilepsy & Neural Plasticity
 At the beginning, weak electrical
stimulation, in the form of a low-amplitude
train of electrical pulses, has no discernible
effect on the animal’s behavior or on the
pattern of electrical activity in the brain
(laboratory rats or mice have typically
been used for such studies).
Epilepsy & Neural Plasticity
 As this weak stimulation is repeated once a
day for several weeks, it begins to produce
behavioral and electrical indications of
seizures.
 By the end of the experiment, the same
weak stimulus that initially had no effect
now causes full-blown seizures.
Epilepsy & Neural Plasticity
 This phenomenon is essentially permanent;
even after an interval of a year, the same
weak stimulus will again trigger a seizure.
 Thus, repetitive weak activation produces
long-lasting changes in the excitability of
the brain that time cannot reverse.
 The word kindling is therefore quite
appropriate: A single match can start a
devastating fire.
Epilepsy & Neural Plasticity
 The changes in the electrical patterns of
brain activity detected in kindled animals
resemble those in human epilepsy.
 The behavioral manifestations of epileptic
seizures in human patients range from mild
twitching of an extremity to loss of
consciousness and uncontrollable
convulsions.
The short-term forms of
plasticity
 Synaptic plasticity mechanisms occur on
time scales ranging from milliseconds to
days, weeks, or longer. The short-term
forms of plasticity—those lasting for
minutes or less
The short-term forms of
plasticity
 Facilitation of the EPP occurs at the
beginning of the stimulus train and is
followed by depression of the EPP.
 After the train of stimuli ends, EPPs are
larger than before the train.
 This phenomenon is called post-tetanic
potentiation.
The Long-term forms of
plasticity
 Some patterns of synaptic activity in the
CNS produce a long-lasting increase in
synaptic strength known as long-term
potentiation (LTP) , whereas other patterns
of activity produce a long-lasting decrease
in synaptic strength, known as long-term
depression (LTD) .
The Long-term forms of
plasticity
 LTP and LTD are broad terms that
describe only the direction of change in
synaptic efficacy; in fact, different cellular
and molecular mechanisms can be
involved in producing LTP or LTD at
different synapses.
The Long-term Potentiation of
Hippocampal Synapses
 The arrangement of neurons allows the
hippocampus to be sectioned such that
most of the relevant circuitry is left intact.
 In such preparations, the cell bodies of the
pyramidal neurons lie in a single densely
packed layer that is readily apparent in the
next figure.
The Long-term Potentiation of
Hippocampal Synapses
 This layer is divided into several distinct
regions, the major ones being CA1 and
CA3.
 “CA” refers to cornu Ammon , the Latin
for Ammon’s horn—the ram’s horn that
resembles the shape of the hippocampus.
The Long-term Potentiation of
Hippocampal Synapses
The Long-term Potentiation of
Hippocampal Synapses
 The dendrites of pyramidal cells in the
CA1 region form a thick band (the stratum
radiatum), where they receive synapses
from Schaffer collaterals, the axons of
pyramidal cells in the CA3 region.
The Long-term forms of
plasticity
 Electrical stimulation of Schaffer
collaterals generates excitatory
postsynaptic potentials (EPSPs) in the
postsynaptic CA1 cells .
 If the Schaffer collaterals are stimulated
only two or three times per minute, the size
of the evoked EPSP in the CA1 neurons
remains constant.
The Long-term forms of
plasticity
 However, a brief, high-frequency train of
stimuli to the same axons causes LTP,
which is evident as a long-lasting increase
in EPSP amplitude .
 LTP occurs not only at the excitatory
synapses of the hippocampus shown, but at
many other synapses in a variety of brain
regions, including the cortex, amygdala,
and cerebellum.
The Long-term forms of
plasticity
Characteristics of LTP
 First, LTP is state-dependent :
The state of the membrane potential of the
postsynaptic cell determines whether or
not LTP occurs ( next figure ).
Characteristics of LTP
If a single weak stimulus to the Schaffer
collaterals—paired with strong
depolarization of the postsynaptic CA1 cell,
the activated Schaffer collateral synapses
undergo LTP.
The increase occurs only if the paired
activities of the presynaptic and postsynaptic
cells are tightly linked in time,

Characteristics of LTP
Characteristics of LTP
 LTP also exhibits the property of input
specificity :
When LTP is induced by the stimulation of
one synapse, it does not occur in other,
inactive synapses that contact the same
neuron .
Thus, LTP is restricted to activated synapses
rather than to all of the synapses on a given
cell
Characteristics of LTP
 Another important property of LTP is
associativity :
As noted, weak stimulation of a pathway will
not by itself trigger LTP.
However, if one pathway is weakly activated
at the same time that a neighboring
pathway onto the same cell is strongly
activated, both synaptic pathways undergo
LTP.
Molecular mechanism of
LTP
 NMDA receptor channel is permeable to
Ca 2+ , but is blocked by physiological
concentrations of Mg 2+ .
 This property provides a critical insight
into how LTP is induced.
Molecular mechanism of
LTP
 During low-frequency synaptic
transmission, glutamate released by the
Schaffer collaterals binds to both NMDA-
type and AMPA/kainate-type glutamate
receptors.
Molecular mechanism of
LTP
 While both types of receptors bind
glutamate, if the postsynaptic neuron is at
its normal resting membrane potential, the
NMDA channels will be blocked by Mg
2+ ions and no current will flow (Left of
next figure).
Molecular mechanism of
LTP
 Because blockade of the NMDA channel
by Mg 2+ is voltage-dependent, the
function of the synapse changes markedly
when the postsynaptic cell is depolarized.
Thus, conditions that induce LTP, such as
high-frequency stimulation will cause a
prolonged depolarization that results in Mg
2+ being expelled from the NMDA
channel (Right of next figure).
Molecular mechanism of
LTP
Molecular mechanism of
LTP
 Removal of Mg 2+ allows Ca 2+ to enter
the postsynaptic neuron and the resulting
increase in Ca 2+ concentration within the
dendritic spines of the postsynaptic cell
turns out to be the trigger for LTP.
Molecular mechanism of
LTP
 The NMDA receptor thus behaves like a
molecular “ and ” gate: The channel opens
(to induce LTP) only when glutamate is
bound to it and the postsynaptic cell is
depolarized to relieve the Mg 2+ block of
the receptor.
 Thus, the NMDA receptor can detect the
coincidence of two events
Molecular mechanism of
LTP
 These properties of the NMDA receptor
can account for many of the characteristics
of LTP.
 The specificity of LTP can be explained by
the fact that NMDA channels will be
opened only at synaptic inputs that are
active and releasing glutamate, thereby
confining LTP to these sites.
Molecular mechanism of
LTP
 With respect to associativity a weakly
stimulated input releases glutamate, but
cannot sufficiently depolarize the
postsynaptic cell to relieve the Mg 2+
block.
 If neighboring inputs are strongly
stimulated, however, they provide the
“associative” depolarization necessary to
relieve the block.
Molecular mechanism of
LTP
 Rise in the concentration of Ca 2+ in the
postsynaptic CA1 neuron, due to Ca 2+
ions entering through NMDA receptors,
serves as a second messenger signal that
induces LTP.
 Cuz injection of Ca 2+ chelators blocks
LTP induction, whereas elevation of Ca 2+
levels in postsynaptic neurons potentiates
synaptic transmission.
Molecular mechanism of
LTP
 Ca 2+ induces LTP by activating
complicated signal transduction cascades
that include protein kinases in the
postsynaptic neuron.
 At least two Ca 2+-activated protein
kinases have been implicated in LTP
induction Ca 2+ /calmodulin-dependent p
rotein kinase (CaMKII) and protein kinase
C .
Molecular mechanism of
LTP
 CaMKII seems to play an especially
important role: This enzyme is the most
abundant postsynaptic protein at Schaffer
collateral synapses, and pharmacological
inhibition or genetic deletion of CaMKII
prevents LTP.
 The downstream targets of these kinases
are not yet fully known, but apparently
include the AMPA class of glutamate
Mechanisms underlying LTP. During glutamate release, the NMDA channel
opens only if the postsynaptic cell is sufficiently depolarized.
The Ca 2+ ions that enter the cell through the channel activate
postsynaptic protein kinases. These kinases may act in postsynaptic
neurons to insert new AMPA receptors into the postsynaptic spine,
thereby increasing the sensitivity to glutamate
Molecular mechanism of
LTP
 LTP arises from changes in the sensitivity
of the postsynaptic cell to glutamate by
adding new AMPA receptors to “silent”
synapses that did not previously have
postsynaptic AMPA receptors.
 Such rapid insertion of new AMPA
receptors also can occur at “non-silent”
excitatory synapses.
LTD
 If synapses simply continued to increase in
strength as a result of LTP, eventually they
would reach some level of maximum
efficacy, making it difficult to encode new
information. Thus, to make synaptic
strengthening useful, other processes must
selectively weaken specific sets of
synapses.
LTD
 Long-term depression (LTD) is such a
process.
 Whereas LTP at these synapses requires
brief, high-frequency stimulation, LTD
occurs when the Schaffer collaterals are
stimulated at a low rate—about 1 Hz—for
long periods (10–15 minutes).
LTD
LTD
 This pattern of activity depresses the EPSP
for several hours and, like LTP, is specific
to the activated synapses
 Moreover, LTD can erase the increase in
EPSP size due to LTP, and, conversely,
LTP can erase the decrease in EPSP size
due to LTD.
LTD
 LTP and LTD at the Schaffer collateral-
CA1 synapses actually share several key
elements. Both require activation of
NMDA-type glutamate receptors and the
resulting entry of Ca 2+ into the
postsynaptic cell.
LTD
The major determinant of whether LTP or
LTD arises appears to be the amount of
Ca 2+ in the postsynaptic cell:
Small rises in Ca 2+ lead to depression,
whereas large increases trigger potentiation.
LTD
LTD, appears to result from activation of Ca
2+-dependent phosphatases that cleave
phosphate groups from these target
molecules .
Just as LTP at this synapse is associated with
insertion of AMPA receptors, LTD is often
associated with a loss of synaptic AMPA
receptors.
LTD
This loss probably arises from internalization
of AMPA receptors into the postsynaptic
cell, due to the same sort of clathrin
dependent endocytosis mechanisms
important for synaptic vesicle recycling in
the presynaptic terminal .
LTD
Glutamatergic Ion Channels
Alterations postulated in
epilepsy
Alterations
1- Inherited predisposition for fast or long-
lasting activation of NMDA channels that
alters their seizure threshold.
2- Other possible alterations include the
ability of intracellular proteins to buffer
calcium, increasing the vulnerability of
neurons to any kind of injury that otherwise
would not result in neuronal death.
“GluR2 hypothesis”
whereby preferential removal of GluR2 (with
no changes in GluR1) can lead to AMPA-
type glutamate receptors that flux calcium.
Alterations
It has now been shown that AMPA-type
glutamate receptors can not only participate
in calcium-dependent plasticity, but can also,
as a result of plasticity, alter their subunit
composition .
It has been known that GluR2-lacking
receptors flux calcium, allowing for this to
occur. Either downregulation of GluR2 or
upregulation of GluR1 would potentially
Alterations
It has been known that GluR2-lacking
receptors flux calcium, allowing for this to
occur, either:
A- down regulation of GluR2 or,
B- up regulation of GluR1.
would potentially lead to more homomeric,
calcium-permeable GluRs.
Decreased Inhibition
PATHOPHYSIOLOGY
The release of GABA from the interneuron
terminal inhibits the postsynaptic neuron by
means of 2 mechanisms:
(1) direct induction of an inhibitory
postsynaptic potential (IPSP), which a
GABA-A chloride current typically
mediates, and
PATHOPHYSIOLOGY
(2) indirect inhibition of the release of
excitatory neurotransmitter in the presynaptic
afferent projection, typically with a GABA-B
potassium current.
Alterations or mutations in the different
chloride or potassium channel subunits or in
the molecules that regulate their function
may affect the seizure threshold or the
propensity for recurrent seizures.
PATHOPHYSIOLOGY
 Properties of the chloride channels
associated with the GABA-A receptor are
often clinically modulated by using
benzodiazepines (eg, diazepam, lorazepam,
clonazepam), barbiturates (eg,
phenobarbital, pentobarbital), or
topiramate.
PATHOPHYSIOLOGY
 Benzodiazepines increase the frequency of
openings of chloride channels, whereas
barbiturates increase the duration of
openings of these channels. Topiramate
also increases the frequency of channel
openings, but it binds to a site different
from the benzodiazepine-receptor site.
Defective GABA-A inhibition
 Some epilepsies may involve mutations or
lack of expression of the different GABA-
A receptor complex subunits, the
molecules that govern their assembly, or
the molecules that modulate their electrical
properties.
 For example, hippocampal pyramidal
neurons may not be able to assemble alpha
5 beta 3 gamma 3 receptors because of
deletion of chromosome 15 (ie, Angelman
syndrome).
Defective activation of GABA
neurons
Feedforward Inhibition
 GABAergic cells receive a collateral
projection from the main afferent
projection that activates the CA1 neurons,
namely, the Schaffer collateral axons from
the CA3 pyramidal neurons.
Feedforward Inhibition
 This feedforward projection activates the
soma of GABAergic neurons before or
simultaneously with activation of the
apical dendrites of the CA1 pyramidal
neurons.
Feedforward Inhibition
 The results in an IPSP on the soma or axon
hillock of the CA1 pyramidal neurons
almost simultaneously with the EPSP from
the apical dendrites to the axon hillock,
thus primes the inhibitory system in a
manner that allows it to inhibit, in a timely
fashion, the pyramidal cell's depolarization
and firing of an action potential.
Alteration
 Synaptic reorganization is a form of brain
plasticity induced by neuronal loss,
perhaps triggered by the loss of the
synaptic connections of the dying neuron,
a process called deafferentation.
Alteration
 Formation of new sprouted circuits
includes excitatory and inhibitory cells,
and both forms of sprouting have been
demonstrated in many animal models of
focal-onset epilepsy and in humans with
intractable temporal-lobe epilepsy.
Alteration
 Most of the initial attempts of hippocampal
sprouting are likely to be attempts to
restore inhibition. As the epilepsy
progresses, however, the overwhelming
number of sprouted synaptic contacts
occurs with excitatory targets, creating
recurrent excitatory circuitries that
permanently alter the balance between
excitatory and inhibitory tone in the
hippocampal network.
Pathophysiology
Generalized Seizures
 The best-understood example of the
pathophysiologic mechanisms of
generalized seizures is the thalamocortical
interaction that may underlie typical
absence seizures.
Pathophysiology
Generalized Seizures
 The thalamocortical circuit has normal
oscillatory rhythms, with periods of
relatively increased excitation and periods
of relatively increased inhibition.
 It generates the oscillations observed in
sleep spindles.
Pathophysiology
Generalized Seizures
The thalamocortical circuitry includes:
The pyramidal neurons of the neocortex.
The thalamic relay neurons .
The neurons in the nucleus reticularis of the
thalamus (NRT).
Thalamic Relay Neurons
 Receive ascending inputs from the spinal
cord and project to the neocortical
pyramidal neurons. Cholinergic pathways
from the forebrain and the ascending
serotonergic, noradrenergic, and
cholinergic brainstem pathways
prominently regulate this circuitry.
Thalamic Relay Neurons
 They can have oscillations in the resting
membrane potential, which increases the
probability of synchronous activation of
the neocortical pyramidal neuron during
depolarization and which significantly
lowers the probability of neocortical
activation during relative
hyperpolarization.
Thalamic Relay Neurons
 The key to these oscillations is the
transient low-threshold calcium channel,
also known as T-calcium current.
 Inhibitory inputs from the NRT control the
activity of thalamic relay neurons.
T-calcium current
 Have 3 functional states: open, closed, and
inactivated.
 Calcium enters the cells when the T-
calcium channels are open. Immediately
after closing, the channel cannot open
again until it reaches a state of inactivation.
T-calcium current
 The thalamic relay neurons have GABA-B
receptors in the cell body and receive tonic
activation by GABA released from the
NRT projection.
 The result is a hyperpolarization that
switches the T-calcium channels away
from the inactive state into the closed state,
which is ready for activation when needed.
T-calcium current
 The switch to closed state permits the
synchronous opening of a large population
of the T-calcium channels every 100
milliseconds or so, creating the oscillations
observed in the EEG recordings from the
cerebral cortex.
T-calcium current
 Findings in several animal models of
absence seizures, have demonstrated that
GABA-B receptor antagonists suppress
absence seizures, whereas GABA-B
agonists worsen these seizures.
 Anticonvulsants that prevent absence
seizures, such as valproic acid and
ethosuximide, suppress the T-calcium
current, blocking its channels.
Pathophysiology
Generalized Seizures
 A clinical problem is that some
anticonvulsants that increase GABA levels
(eg, tiagabine, vigabatrin) are associated
with an exacerbation of absence seizures.
An increased GABA level is thought to
increase the degree of synchronization of
the thalamocortical circuit and to enlarge
the pool of T-calcium channels available
for activation.
Natural History of Seizures
 At least 60% of newly diagnosed patients
can expect complete seizure control.
 Approximately 50% of these patients can
discontinue medication.
 Up to one third of premature deaths can be
directly or indirectly attributable to
epilepsy.
 Mortality is significantly higher if :
1- Symptomatic epilepsy.
2- In the first 5 to 10 years after diagnosis of
epilepsy
3- younger pt.
Natural History of Seizures
 Major contributors to death in patients with
epilepsy are :
1- Neoplasia.
2- Cerebrovascular disorders.
3- Pneumonia in elderly or institutionalized
patients.
Natural History of Seizures
Natural History of Seizures
 SUDEP is the most important cause of
epilepsy-related deaths, particularly in the
young, and people with frequent seizures
and/or suboptimal AED treatment.
 Appropriate postmortem investigations
should be conducted in order to accurately
classify the cause of death.
AURA
 The aura, of course, is the start, not the
cause, of a seizure.
 The aura usually lasts seconds to minutes
and immediately precedes the signs of an
attack.
 On occasion, auras can be long-lasting,
continuous, or recurrent with short
intervening breaks.
Somatosensory
 Tingling, numbness, and an electrical
feeling are common, whereas absence of
sensation or a sensation of movement is
less.
Cephalic
 Ill-defined sensations felt within the head,
such as dizziness, electrical shock,
tingling, fullness, or pressure.
 No specific site, and related to an alteration
of circulation.
Psychical
 “certain psychical states during the onset
of epileptic seizures” that included
“intellectual aura … dreamy feelings ...
dreams mixing up with present thoughts ...
double consciousness ... ‘as if I went back
to all that occurred in my childhood’.
 psychic auras can occur with focal
seizures from anywhere in the brain
Visual
 Spots, stars, blobs, bars, or circles of light,
monochromatic or variously colored,
implicate seizure activity in the visual
areas of the occipital lobes
Auditory
 ringing, booming, buzzing, chirping, or
machinelike .
 A lateralized sound is usually contralateral
to the side of stimulation. At other times,
partial deafness may occur.
 Auras with such unformed auditory
hallucinations suggest seizure activity in
the superior temporal neocortex
Olfactory
 The smell of an olfactory aura is often
unpleasant or disagreeable.
 Other than the medial temporal lobe, the
olfactory bulb is the only structure that can
produce an olfactory sensation on
electrical stimulation.
Vertiginous
 Stimulation of the superior temporal gyrus
can elicit feelings of displacement or
movement, including rotatory sensations
Others
 Gustatory
 Sexual
 Autonomic
 Emotional
Epileptic Seizures
Generalized Onset
A) seizures with tonic–clonic manifestations
I) Clonic seizures: clonic seizures are fast
rhythmic events (1–2 Hz), often associated
with impaired consciousness.
Generalized Onset
A) seizures with tonic–clonic manifestations
II) Tonic seizures: the mechanism of tonic
seizures is probably not the same as that of
the tonic phase of generalized tonic– clonic
seizures.
Generalized tonic seizures typically occur in
Lennox–Gastaut syndrome and occasionally
in epilepsy with myoclonic astatic (or
myoclonic-atonic) seizures.
Generalized Onset
A) seizures with tonic–clonic manifestations
III) Generalized tonic–clonic seizures
(GTCSs) have sudden onset with immediate
loss of consciousness.
Generalized Onset
A) seizures with tonic–clonic manifestations
 There is a brief tonic phase (10–30
seconds) with whole body tonic
contraction, associated with a loud scream
and vegetative symptoms such as
tachycardia, mydriasis, increased blood
pressure, and apnoea.
Generalized Onset
A) seizures with tonic–clonic manifestations
 Tongue biting if present, is produced at
this stage.
 The clonic phase lasts around 30 seconds
— 1 minute and is characterized by
bilateral clonic jerks that gradually
decrease in intensity and frequency.
Generalized Onset
A) seizures with tonic–clonic manifestations
 The postictal phase, which can last for
several minutes up to hours, is
characterized by initial mydriasis, body
relaxation, hypotonia, and sleep.
 Urination if present, takes place at this
stage.
 Finally the patient gradually recovers and
appears confused, presenting sometimes
with automatisms, headache, and muscle
Generalized Onset
B) Myoclonic seizures
 Myoclonic seizures are manifested as brief
symmetrical muscular jerks of variable
intensity.
 Proximal muscles such as girdle muscles
are mostly involved.
 During stronger attacks, there is possibility
of the patient falling over, but quickly
recovering.
Generalized Onset
B) Myoclonic seizures
 The patient is usually conscious during the
jerks. Myoclonic seizures may often be
triggered by photic stimulation.
Generalized Onset
C) Absences
 Typical absence seizures are brief (5–12
seconds).
 They appear mostly in children and are
clinically characterized by sudden
interruption of ongoing activity and staring
straight ahead or drifting upwards.
 There is complete loss of awareness during
the seizure.
Generalized Onset
C) Absences
 The onset and offset is sharp.
 Absence seizures can be easily produced if
the child is asked to hyperventilate.
 Concomitant EEG abnormalities are
typical generalized spike-and wave
discharge at 3 Hz.
Generalized Onset
C) Absences
 Possible associated manifestations include
slight rhythmic (3 Hz) eyelid myoclonus,
slight decrement or increment of muscle
tone, simple gestural automatisms (if the
absence is of long duration), and, rarely,
vegetative symptoms (urinary
incontinence, pupil dilatation, pallor,
flushing, tachycardia, change in blood
pressure).
Generalized Onset
D) Epileptic spasms
 These consist of a brief (0.5–2 second)
tonic contraction of the neck and trunk in
flexion, extension or in a mixed flexed-
extended posture.
 They occur most commonly in clusters
upon awakening.

Generalized Onset
D) Epileptic spasms
 Each cluster consists of several spasms the
intensity and frequency of which follow an
increasing-plateau-decreasing pattern.
 Therefore the first spasms in a cluster can
be barely visible, presenting a forced
opening of the eyes or slight nodding of
the head.
Generalized Onset
D) Epileptic spasms
 Ictal EEG is characterized by pseudo-
periodic slow polyphasic EEG discharges
that are concomitant to spasms.
 EEG activity related to spasms can also be
a bilateral electrodecremental pattern.
 Electromyographic activity from deltoid
and neck muscles shows a characteristic
rhomboid pattern during the spasm, usually
lasting 0.5–2 seconds
Generalized Onset
E) Atonic seizures
 Atonic seizures are characterized by
decrease or complete inhibition of postural
tone.
 They manifest as head nodding, dropping
of the jaw or of a limb, or falls.
Generalized Onset
E) Atonic seizures
 The patient can then lie motionless on the
ground or promptly resume the posture.
Pure atonic seizures are rare.
 Ictal EEG is usually characterized by a
generalized slow spike-and-wave
discharge.
Focal Onset
A) Focal sensory seizures.
I) With elementary sensory
(visual, somatosensory, vestibular, olfactory,
gustatory, or auditory) symptoms as
produced by activation of primary sensory
cortices (e.g. occipital and parietal lobe
seizures).
Focal Onset
A) Focal sensory seizures.
II) With experiential symptoms.
These are complex, formed, distorted and/or
multimodal sensory symptoms, usually
implying seizure initiation in association
cortices, such as the temporo-parieto-
occipital junction.
 B) Focal motor seizures. I) With
elementary clonic motor signs. II) With
asymmetric tonic motor seizures (e.g.
Focal Onset
B) Focal motor seizures.
I) With elementary clonic motor signs.
II) With asymmetric tonic motor seizures
(e.g. supplementary motor seizures).
III) With typical (temporal lobe)
automatisms (e.g. mesial temporal lobe
seizures).
IV) With hyperkinetic automatisms.
V) With focal negative myoclonus.
VI) With inhibitory motor seizures.
Lobar epilepsy
Temporal lobe
 Automatisms—complex motor
phenomena, but with impaired awareness
and no recollection afterwards, varying
from primitive oral (lip smacking,
chewing, swallowing) or manual
(fumbling, fiddling, grabbing) movements,
to complex actions (singing, kissing,
driving a car and violent acts) •
Lobar epilepsy
Temporal lobe
 Abdominal rising sensation or pain (± ictal
vomiting; or rarely episodic fevers.
 Dysphasia (ictal or post-ictal)
 Memory phenomena—déjà vu (when
everything seems strangely familiar), or
jamais vu (everything seems strangely
unfamiliar)
Lobar epilepsy
Temporal lobe
 Hippocampal involvement may cause
emotional disturbance, eg sudden terror,
panic, anger or elation, and derealization
(out-of-body experiences), which in
combination may manifest as excessive
religiosity.
Lobar epilepsy
Temporal lobe
 Uncal involvement may cause
hallucinations of smell or taste and a
dreamlike state, and seizures in auditory
cortex may cause complex auditory
hallucinations, eg music or conversations.
 Delusional behaviour;
Lobar epilepsy
Temporal lobe
 Finally, you may find yourself not
believing your patient’s bizarre story—eg
“Canned music at Tesco’s always makes
me cry and then pass out, unless I wear an
earplug in one ear” or “I get orgasms when
I brush my teeth” (right temporal lobe
hyper- and hypo perfusion, respectively).
Frontal lobe
 Motor features such as posturing,
movements of the head and eyes,or
peddling movements of the legs
 Jacksonian march (a spreading focal motor
seizure with retained awareness, often
starting with the face or a thumb)
 Motor arrest
Frontal lobe
 Subtle behavioural disturbances (often
diagnosed as psychogenic)
 Dysphasia or speech arrest
 Post-ictal Todd’s palsy
Parietal lobe
 Sensory disturbances—tingling, numbness,
pain (rare)
 Motor symptoms (due to spread to the pre-
central gyrus).
Occipital lobe
 Visual phenomena such as spots, lines,
flashes.
Classification of The Epilepsies
And of Epilepsy Syndrome
Partial & Generalized
 In 1981 the International League Against
Epilepsy (ILAE) Commission on
Classification and Terminology proposed
an International Classification of Epileptic
Seizures .
 Seizures were classified as partial and
generalized (Next table) .
Partial & Generalized
 Seizures were defined as partial if the first
clinical and electroencephalographic
(EEG) signs indicated that initial activation
was limited to part of one cerebral
hemisphere.
 Partial seizures were classified in simple or
complex on the basis of whether or not
awareness was impaired during the attack.
Partial & Generalized
 Seizures were considered as generalized if
the first clinical and EEG changes
indicated the initial involvement of both
hemispheres.
Syndromic Classification
 The Commission adopted a syndromic
classification.
 A syndrome was considered as a group of
signs and symptoms customarily occurring
in association, including seizure types,
clinical background, neurophysiological
and neuroimaging findings and, often,
outcome (Next table ) .
Syndromic Classification
 According to symptoms, epilepsies were
classified as generalized and partial (or
focal).
 Generalized epilepsies were defined as
characterized by generalized seizures,
bilateral motor manifestations, and
generalized interictal and ictal EEG
discharges.
Syndromic Classification
 Partial epilepsies were those characterized
by seizures originating from a
circumscribed brain region, and by clinical
manifestations consistent with a focal onset
of the epileptic discharge, with or without
subsequent spread, and by focal ictal or
interictal EEG abnormalities.
Idiopathic VS Symptomatic
 The 1989 Classification also divided the
epilepsies by aetiology, into two broad
categories: idiopathic and symptomatic
epilepsies.
Idiopathic VS Symptomatic
 Idiopathic epilepsies were defined by
absence of any brain lesions, normal
background EEG activity and interictal
generalized spike and wave discharges.
They were considered to be due to a
genetic predisposition or to a specific mode
of inheritance.
Idiopathic VS Symptomatic
 Symptomatic epilepsies were considered
the expression of a focal or diffuse brain
lesion as demonstrated by clinical history,
structural neuroimaging, EEG findings, or
biological tests.
Unclassified Seizures
B. UNCLASSIFIED SEIZURES
i. Neonatal seizures
ii. Infantile spasms
Neonatal Seizure
 Less than 1 month of age.
 Brief episodes of apnea, eye deviation, eye
blinking, or repetitive movements of the
arms and legs.
Infantile Spasms
 Infants under 12 months.
 Abrupt movements of the head, trunk, or
limbs.
 The classic spasm is a sudden flexion of
the neck and abdomen with extension of
the limbs.
Differential diagnoses of
epilepsy
Ultimately, the rationale for diagnostic studies is to provide the patien
with effective therapy. The goals of therapy are no seizures, no side
effects, and no lifestyle limitations.
General Considerations
 The initial diagnostic approach to the
patient with epilepsy and related episodic
disorders has importance for both long-
term prognosis and treatment, including
the determination of:
1- whether treatment is necessary
2- The type(s) of therapy to be considered.
General Considerations
 When evaluating a patient with possible
epilepsy, the basic approach is as follows:
Is this epilepsy, and, if so, is it focal or
generalized, Any triggers?
 Once a seizure is determined to be a
manifestation of epilepsy, a diagnostic
workup must be performed to understand
the underlying cause(s) and epilepsy
syndrome type when possible
Essential for the diagnosis
1) Recurrent seizures.
2) Characteristic electroencephalographic
changes accompany seizures.
3) Mental status abnormalities or focal
neurologic symptoms may persist for
hours postictally.
First Seizure
In assessing a first-ever seizure, consider
also:
1- Is it really the first? Ask the family and
patient about past funny turns/odd behaviour.
2- Déjà vu and odd episodic feelings of fear
may well be relevant.
First Seizure
3- Was the seizure provoked? Provoked 1st
seizures are less likely to recur (3–10%,
unless the cause is irreversible, eg an infarct
or glioma); if it was unprovoked, recurrence
rates are 30–50%.
First Seizure
provocations are different to triggers: most
people would have a seizure given sufficient
provocation, but most people do not have
seizures however many triggers they are
exposed to, so triggered seizures suggest
epilepsy.
First Seizure
Triggered attacks tend to recur.
Admit to substantiate ideas of
pseudoseizures, or for recurrent seizures.
Laboratory studies
 Electrolytes
 Glucose
 Ca
 Mg
 Liver and renal function test
 Urianalysis
 Toxicology screen
 Lumbar puncture
EEG Clinical Applications
1- Diagnosis of epilepsy.
2- Selection of AED therapy.
3- Evaluation of response to treatment.
4- Determination of candidacy for drug
withdrawal.
5- Surgical localization.
EEG
 An EEG cannot exclude or refute epilepsy;
it forms part of the context for diagnosis,
so don’t do one if simple syncope is the
likely diagnosis (often false +ve).
EEG
 In 1st unprovoked fits, unequivocal
epileptiform activity on EEG helps assess
risk of recurrence, based on studies in both
adults and children, with recurrence rates
that range from 30% to 70% in the first
year.
 Therefore, when the EEG shows an
epileptiform discharge after a single
seizure, treatment may be considered even
before a diagnosis of epilepsy is
established.
 Only do emergency EEGS if non-
convulsive status is the problem .
EEG
 Epileptiform abnormalities usually appear
as spikes, sharp waves, or spike-wave
discharges that are distinct from the normal
background activity and indicate an
increased seizure tendency.
 The spike discharges are predominantly
negative transients with steep ascending
and descending limbs and a duration of 20
ms to 70 ms.
 A sharp wave is a broader potential with a
duration of 70 ms to 200 ms.
Sensitivity & Specificity
 The sensitivity of a single EEG study to
record an epileptiform abnormality may be
50% or less in people with epilepsy so
normal interictal EEG studies do not
exclude the presence of a seizure disorder.
 The diagnostic yield increases to 80% to
90% if three or more serial EEGs are
performed.
EEG
 Ultimately, epilepsy is a clinical diagnosis
and the EEG serves to provide supporting
evidence; in other words, you treat the
patient and not the EEG.
The presence of an epileptiform abnormality
does not always indicate a seizure disorder
 Interictal epileptiform discharges are seen
rarely in adults or children without
epilepsy (0.2% to 3%).
 Healthy airline personnel who underwent
EEG studies.
 Occipital spikes have been observed in
blind people.
The presence of an epileptiform abnormality
does not always indicate a seizure disorder
 Generalized spikes have been reported in
relatives of patients with genetic
generalized epilepsies.
 Interictal epileptiform discharges may also
be seen in patients receiving bupropion,
cefepime, clozapine, lithium, and tramadol,
and in pt with renal failure or an acute
encephalopathy.
Factors That May Affect The
Diagnostic Yield of EEG
(1) The age of the patient
(2) Seizure classification and epileptic
syndrome diagnosis
(3) Presence of AED therapy
(4) Proximity of the EEG recording to
seizure activity (since patients with more
recent seizures more frequently have
diagnostic EEG recordings).
Indications for video-EEG
 Evaluation of spells.
 Seizure classification.
 Seizure quantification.
 Assessment of seizure precipitating factors.
 Surgical localization in drug-resistant
focal epilepsy.
MRI
 Is the structural neuroimaging procedure of
choice in people with epilepsy.
 All individuals with seizures should
undergo an MRI study unless the patient
has a confirmed genetic generalized
epilepsy syndrome (eg, childhood absence
epilepsy) or a contraindication exists that
does not permit this imaging procedure to
be done safely
MRI Help In
 Identification of the pathologic findings
associated with focal or generalized
seizures.
 Localization of the epileptogenic zone.
 Determination of surgical localization in
drug-resistant focal epilepsy
Management
The basic goals of treatment for
epilepsy are to:
1- Help the patient achieve freedom from
further seizures without adverse effects of
therapies.
2- Minimize the frequency of disabling or
potentially injurious seizure types when
seizure freedom is not achieved.
3- Address any relevant interictal
comorbidities of epilepsy to maximize
quality of life for people with epilepsy.
Starting treatment
 Single seizures: No treatment unless there
is a high risk of recurrence, e.g. abnormal
EEG as in JME or an abnormal MRI. If
precipitating factors (e.g. alcohol)
identified, avoidance may prevent
recurrence
Starting treatment
 After a single unprovoked seizure, risk of
recurrence is 24% with no cause and
normal EEG. and 65% if associated with a
neurological abnormality + abnormal
EEG.
Starting treatment
 Prophylaxis : No indication for starting
treatment in patients with head injuries,
craniotomy, brain tumours, unless seizures
occur.
 Drug treatment Aim of treatment is to
render patient seizure-free with minimal
side-effects.
 Other factors include sudden unexpected
death in epilepsy (SUDEP)— 1/200/year
in refractory epilepsy. –
 Factors to be taken into account:
- age;
- sex;
- type of epilepsy;
- other drugs, e.g. contraceptive pill; - other
medical conditions, e.g. liver or renal
dysfunction.
 Treatment is initiated at low dose gradually
titrating to an effective level to avoid side-
effects (‘start low, go slow’).
- If seizures continue, increase dose to
maximum tolerated.
- If seizures continue, withdraw first drug
and try another first-line drug.
- If unsuccessful, adjunctive treatment with a
second-line drug should be considered.
Surgery
 Should be considered, and patients referred
to a specialist centr, in cases with:
- Surgically resectable lesion.
- Temporal lobe seizures in whom there is
evidence of mesial temporal sclerosis
- In such patients seizure-free rates 80%,
with 3–4% permanent neurological deficit
and 1% mortality rates.
Vagus nerve stimulation
 is an option with no serious side-effects in
those with refractory epilepsy, and
unsuitable for surgery.
Counselling After any ‘fit’
Advise about dangers (eg swimming,
driving, heights) until the diagnosis is
known; then give individualized counselling
on employment, sport, insurance and
conception .
Avoid driving until seizure free for >1yr.

More Related Content

What's hot

EPILEPSY
EPILEPSYEPILEPSY
EPILEPSY
GamitKinjal
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
Brian Piper
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Dr Nag Raj
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Meghana Gowda
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
Dr. Ramesh Bhandari
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s disease
Akhil Joseph
 
Migraine
MigraineMigraine
Migraine
Pramod Krishnan
 
PARKINSON’S DISEASE
PARKINSON’S DISEASEPARKINSON’S DISEASE
PARKINSON’S DISEASE
Dr. Kapil Dev Doddamani
 
Acute management of seizure
Acute management of seizureAcute management of seizure
Acute management of seizure
sunil kumar daha
 
NEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASESNEURO DEGENERATIVE DISEASES
Alzheimer disease
Alzheimer disease Alzheimer disease
Alzheimer disease
Tarek Gouda
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Sanjay K
 
Epilepsy.....
Epilepsy.....Epilepsy.....
Epilepsy.....
Ravneet Singh
 
PARKINSON'S DISEASE Presentation by Rajee
PARKINSON'S DISEASE  Presentation by RajeePARKINSON'S DISEASE  Presentation by Rajee
PARKINSON'S DISEASE Presentation by Rajee
Rajee Ravindran
 
Migraine
MigraineMigraine
Migraine
Ahmed Abouelela
 
Seizures
SeizuresSeizures
Seizures
ParthibanArasu
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
Sanil Varghese
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Aaqib Naseer
 

What's hot (20)

EPILEPSY
EPILEPSYEPILEPSY
EPILEPSY
 
Pathophysiology: Migraine & Headache
Pathophysiology: Migraine & HeadachePathophysiology: Migraine & Headache
Pathophysiology: Migraine & Headache
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Lewy Body Dementia
Lewy Body DementiaLewy Body Dementia
Lewy Body Dementia
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s disease
 
Migraine
MigraineMigraine
Migraine
 
PARKINSON’S DISEASE
PARKINSON’S DISEASEPARKINSON’S DISEASE
PARKINSON’S DISEASE
 
Acute management of seizure
Acute management of seizureAcute management of seizure
Acute management of seizure
 
NEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASESNEURO DEGENERATIVE DISEASES
NEURO DEGENERATIVE DISEASES
 
Alzheimer disease
Alzheimer disease Alzheimer disease
Alzheimer disease
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Epilepsy.....
Epilepsy.....Epilepsy.....
Epilepsy.....
 
PARKINSON'S DISEASE Presentation by Rajee
PARKINSON'S DISEASE  Presentation by RajeePARKINSON'S DISEASE  Presentation by Rajee
PARKINSON'S DISEASE Presentation by Rajee
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
Migraine
MigraineMigraine
Migraine
 
Seizures
SeizuresSeizures
Seizures
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 

Viewers also liked

Diagnosis of epilepsy
Diagnosis of epilepsyDiagnosis of epilepsy
Diagnosis of epilepsy
Amr Hassan
 
Epilepsy
EpilepsyEpilepsy
Epilepsyjudhai
 
Epilepsy (seizure disorder)
Epilepsy (seizure disorder)Epilepsy (seizure disorder)
Epilepsy (seizure disorder)
Heena Gupta
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentationTaher Haddad
 
Epilepsy
Epilepsy Epilepsy
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
JYOTI PACHISIA
 
Pathophysiology of tonic clonic seizure
Pathophysiology of tonic clonic seizure Pathophysiology of tonic clonic seizure
Pathophysiology of tonic clonic seizure
Abigail Abalos
 
Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.
Tarun Prudvi Betha
 
Pathology of Epilepsy
Pathology of EpilepsyPathology of Epilepsy
Pathology of EpilepsyML Cohen
 
Parkinson's Disease
Parkinson's Disease Parkinson's Disease
Parkinson's Disease
Antru Sinthujan
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
aishuanju
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
Akshu Agrawal
 
Epilepsy & its management
Epilepsy & its managementEpilepsy & its management
Epilepsy & its managementWaliullah Wali
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
Tikal Kansara
 

Viewers also liked (20)

Diagnosis of epilepsy
Diagnosis of epilepsyDiagnosis of epilepsy
Diagnosis of epilepsy
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Epilepsy (seizure disorder)
Epilepsy (seizure disorder)Epilepsy (seizure disorder)
Epilepsy (seizure disorder)
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Quiz
QuizQuiz
Quiz
 
Epilepsy and its causes
Epilepsy and its causesEpilepsy and its causes
Epilepsy and its causes
 
Bipolar Disorders
Bipolar DisordersBipolar Disorders
Bipolar Disorders
 
Epilepsy
Epilepsy Epilepsy
Epilepsy
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
What is schizophrenia
What is schizophreniaWhat is schizophrenia
What is schizophrenia
 
Pathophysiology of tonic clonic seizure
Pathophysiology of tonic clonic seizure Pathophysiology of tonic clonic seizure
Pathophysiology of tonic clonic seizure
 
Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.Epilepsy- classification and types in children. Download to see videos.
Epilepsy- classification and types in children. Download to see videos.
 
Pathology of Epilepsy
Pathology of EpilepsyPathology of Epilepsy
Pathology of Epilepsy
 
Parkinson's Disease
Parkinson's Disease Parkinson's Disease
Parkinson's Disease
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Epilepsy & its management
Epilepsy & its managementEpilepsy & its management
Epilepsy & its management
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 

Similar to Epilepsy

Epileptogenesis
EpileptogenesisEpileptogenesis
Epileptogenesis
Ahmed Mamdouh
 
Epilepsy in Children.pptx
Epilepsy in Children.pptxEpilepsy in Children.pptx
Epilepsy in Children.pptx
CSN Vittal
 
Seizure Disorders in Children
Seizure Disorders in ChildrenSeizure Disorders in Children
Seizure Disorders in Children
CSN Vittal
 
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdfEPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
Adamu Mohammad
 
Powerpoint
PowerpointPowerpoint
Powerpointerinhunt
 
seizure III.pptx
seizure III.pptxseizure III.pptx
seizure III.pptx
MebratGebreyesus
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
Siddharth Singh
 
Epilepsy
EpilepsyEpilepsy
Basic mechanism of epilepsy
Basic mechanism of epilepsyBasic mechanism of epilepsy
Basic mechanism of epilepsy
Pramod Krishnan
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
DRx Lalit Borse
 
MANAGEMENT OF EPILEPSY MODIFIED 2.pptx
MANAGEMENT OF EPILEPSY MODIFIED 2.pptxMANAGEMENT OF EPILEPSY MODIFIED 2.pptx
MANAGEMENT OF EPILEPSY MODIFIED 2.pptx
JENNIFERENEKWECHI
 
MANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSYMANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSY
sethafrifa
 
epilepsy.pptx
epilepsy.pptxepilepsy.pptx
epilepsy.pptx
MohammedAbdela7
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
Zeeshan Khan
 
EPILEPSY.pptx
EPILEPSY.pptxEPILEPSY.pptx
EPILEPSY.pptx
Ravilla Jyothsna Naidu
 
Seizure
SeizureSeizure
Seizure
RijoLijo
 

Similar to Epilepsy (20)

Epileptogenesis
EpileptogenesisEpileptogenesis
Epileptogenesis
 
Epilepsy in Children.pptx
Epilepsy in Children.pptxEpilepsy in Children.pptx
Epilepsy in Children.pptx
 
Seizure Disorders in Children
Seizure Disorders in ChildrenSeizure Disorders in Children
Seizure Disorders in Children
 
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdfEPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
EPILEPSY CLASSIFICATION, PATHOENESIS, AND MANAGEMENT.pdf
 
Powerpoint
PowerpointPowerpoint
Powerpoint
 
Powerpoint
PowerpointPowerpoint
Powerpoint
 
seizure III.pptx
seizure III.pptxseizure III.pptx
seizure III.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
E P I L E P S Y U P D A T E
E P I L E P S Y  U P D A T EE P I L E P S Y  U P D A T E
E P I L E P S Y U P D A T E
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Basic mechanism of epilepsy
Basic mechanism of epilepsyBasic mechanism of epilepsy
Basic mechanism of epilepsy
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
MANAGEMENT OF EPILEPSY MODIFIED 2.pptx
MANAGEMENT OF EPILEPSY MODIFIED 2.pptxMANAGEMENT OF EPILEPSY MODIFIED 2.pptx
MANAGEMENT OF EPILEPSY MODIFIED 2.pptx
 
MANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSYMANAGEMENT OF EPILEPSY
MANAGEMENT OF EPILEPSY
 
33
3333
33
 
epilepsy.pptx
epilepsy.pptxepilepsy.pptx
epilepsy.pptx
 
Epilepsy and Seizures, e-Medicine Article
Epilepsy and Seizures, e-Medicine ArticleEpilepsy and Seizures, e-Medicine Article
Epilepsy and Seizures, e-Medicine Article
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
EPILEPSY.pptx
EPILEPSY.pptxEPILEPSY.pptx
EPILEPSY.pptx
 
Seizure
SeizureSeizure
Seizure
 

More from Mogahed Hussein

The physiology of human Sexual intercourse
The physiology of human Sexual intercourse The physiology of human Sexual intercourse
The physiology of human Sexual intercourse
Mogahed Hussein
 
Understand, evaluate, diagnose and treat stridor trough clinical cases
Understand, evaluate, diagnose and treat stridor trough clinical casesUnderstand, evaluate, diagnose and treat stridor trough clinical cases
Understand, evaluate, diagnose and treat stridor trough clinical cases
Mogahed Hussein
 
Digoxin
DigoxinDigoxin
Hypertension in children
Hypertension in children Hypertension in children
Hypertension in children
Mogahed Hussein
 
AAN certifecate
AAN certifecateAAN certifecate
AAN certifecate
Mogahed Hussein
 
3024196 3 cgyx5
3024196 3 cgyx53024196 3 cgyx5
3024196 3 cgyx5
Mogahed Hussein
 

More from Mogahed Hussein (10)

The physiology of human Sexual intercourse
The physiology of human Sexual intercourse The physiology of human Sexual intercourse
The physiology of human Sexual intercourse
 
Understand, evaluate, diagnose and treat stridor trough clinical cases
Understand, evaluate, diagnose and treat stridor trough clinical casesUnderstand, evaluate, diagnose and treat stridor trough clinical cases
Understand, evaluate, diagnose and treat stridor trough clinical cases
 
Digoxin
DigoxinDigoxin
Digoxin
 
Hypertension in children
Hypertension in children Hypertension in children
Hypertension in children
 
lymphoma
lymphomalymphoma
lymphoma
 
Fluid and electrolytes
Fluid and electrolytes Fluid and electrolytes
Fluid and electrolytes
 
Shock
ShockShock
Shock
 
PFT
PFTPFT
PFT
 
AAN certifecate
AAN certifecateAAN certifecate
AAN certifecate
 
3024196 3 cgyx5
3024196 3 cgyx53024196 3 cgyx5
3024196 3 cgyx5
 

Recently uploaded

Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
nodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptxnodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptx
alishadewangan1
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
tonzsalvador2222
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Studia Poinsotiana
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
ChetanK57
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
YOGESH DOGRA
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
NoelManyise1
 

Recently uploaded (20)

Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
nodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptxnodule formation by alisha dewangan.pptx
nodule formation by alisha dewangan.pptx
 
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityDeep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
Chapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisisChapter 12 - climate change and the energy crisis
Chapter 12 - climate change and the energy crisis
 
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATIONPRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
PRESENTATION ABOUT PRINCIPLE OF COSMATIC EVALUATION
 
Mammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also FunctionsMammalian Pineal Body Structure and Also Functions
Mammalian Pineal Body Structure and Also Functions
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiologyBLOOD AND BLOOD COMPONENT- introduction to blood physiology
BLOOD AND BLOOD COMPONENT- introduction to blood physiology
 

Epilepsy

  • 2.  An estimated 40 million individuals worldwide have epilepsy.  This estimate is based on epidemiological data gathered as part of the Global Burden of Disease (GBD)
  • 3. Epidemiology  Mortality data from GBD, a traditional measure of burden of disease, indicates that 142,000 persons with epilepsy die annually, equating to 0.2% of all deaths worldwide.
  • 4. Epidemiology  Acknowledging the need to define burden beyond mortality, the GBD study introduced a new measure of burden of diseases, injuries, and risk factors, the DALY (disability adjusted life year).
  • 5. Epidemiology  One DALY equates to 1 year of healthy life lost due to disability or poor health. Epilepsy is estimated to contribute 7,854,000 DALYs (0.5%) to the global burden of disease.
  • 6. Epidemiology  A clear pattern emerges from the GBD data whereby over half of all deaths and half of all years of healthy life lost to epilepsy occur in low-income countries.
  • 7. Epidemiology  Moreover, almost one in five of all deaths and almost one in four of all years of healthy life lost to epilepsy worldwide occur among children living in low-income countries.
  • 8. Epidemiology  A major contributor in low-income countries is the “treatment gap,” that is, the difference between the number of individuals with active epilepsy and the number who are being appropriately treated at a given point in time.
  • 9. Epidemiology  Estimates suggest that up to 90% of people with epilepsy in resource-poor countries are inadequately treated .
  • 10. Epidemiology  The burden of epilepsy, however, extends beyond physical health status. Stigma and discrimination are common features of the condition worldwide.
  • 11. Epidemiology  Profound social isolation, feeling of shame and discomfort, and higher risk of psychiatric disorder are among a host of variables contributing to a compromised quality of life.
  • 13. DEFINITIONS  A seizure is a paroxysmal event due to abnormal, excessive, hypersynchronous discharges from an aggregate of central nervous system (CNS)neurons (cortical neurons).  Have various manifestations.
  • 14. DEFINITIONS  A seizure that occurs in the absence of an acute provoking event is considered unprovoked  An acute provoked seizure is one that occurs in the context of an acute brain insult or systemic disorder, such as, but not limited to, stroke, head trauma, a toxic or metabolic insult, or an intracranial infection
  • 15. DEFINITIONS Epileptic seizure: Is a “transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain”.
  • 16. DEFINITIONS Epileptic seizures must be distinguished from nonepileptic seizures and from other conditions that may produce clinical manifestations that are highly similar to those caused by epileptic seizures.
  • 17. DEFINITIONS Epilepsy : (recurrent, unprovoked seizures) individual have at least two unprovoked seizures on separate days, generally 24 hours apart.
  • 18. DEFINITIONS  An individual with a single unprovoked seizure or with two or more unprovoked seizures within a 24-hour period is typically not at that time considered to have met the criteria for labeling him with the diagnosis of epilepsy per se
  • 19. Epilepsy Syndromes Epilepsy, like cancer, is not a single disorder, and the efforts to identify specific forms of epilepsy reflect the importance of the diversity within the epilepsies.
  • 20. Epilepsy Syndromes The epilepsy syndromes represent forms of epilepsy that have different causes, different manifestations, different implications for short- and long-term management and treatment, and different outcomes
  • 22. PATHOPHYSIOLOGY Those questions were as follows: (i)what are the long-term consequences of seizures? Can these be modified? (ii)what is the best anticonvulsant therapy? (iii) What is the best antiepileptogenic therapy?
  • 23. PATHOPHYSIOLOGY  From these questions, the mechanisms of seizure initiation, prolongation, and termination must be addressed, and their sequelae defined.  Further, the mechanisms underlying the development of spontaneous repetitive seizures (SRS) (epileptogenesis) and associated cognitive dysfunction must begin to be addressed.
  • 24. PATHOPHYSIOLOGY Focal-Onset Seizures  The following mechanisms may coexist in different combinations to cause focal-onset seizures: 1- Increased activation 2- Decreased inhibition 3-Defective activation of (GABA) neurons
  • 26. PATHOPHYSIOLOGY Beginning with receptor activation, followed by alterations in membrane polarization, potentially loops around to result in alterations of the properties of the initial trigger of receptor activation.
  • 27. PATHOPHYSIOLOGY Such a loop likely underlies normal plasticity associated with processes like learning and memory, but perhaps becomes unstable with seizures and epileptogenesis, leading to aberrant plasticity that could result in both seizures and cognitive dysfunction
  • 29. Glutamatergic Ion Channels  Glutamate is the major excitatory neurotransmitter in the brain.  The release of glutamate causes an EPSP in the postsynaptic neuron by activating the families of glutamate-activated ligand- gated cation channels.
  • 30. Glutamatergic Ion Channels  classified according to their preferred agonists: 1- kainate, -amino-3-hydroxy-5-methyl-4- isoxazole propionate (AMPA) = (GluR1-4) and (GluR5-7) 2- N-methyl-D-aspartate (NMDA) = (NR1, NR2A-D)
  • 31. Glutamatergic Ion Channels  Calcium influx through NRs is thought to mediate the calcium-activated processes involved in long-term potentiation and depression (LTP and LTD) which are thought to be synaptic models of learning and memory .  They participate in the induction of plasticity in this fashion.
  • 33. Neural Plasticity  The capacity of the nervous system to change—generally referred to as neural plasticity  plasticity is so fundamental that its essential cellular and molecular underpinnings are likely to be conserved in the nervous systems of very different organisms.
  • 34. Epilepsy & Neural Plasticity It seems likely that abnormal activity generates plastic changes in cortical circuitry that are critical to the pathogenesis of the disease. The importance of neuronal plasticity in epilepsy is indicated most clearly by an animal model of seizure production called kindling.
  • 35. Epilepsy & Neural Plasticity  To induce kindling, a stimulating electrode is implanted in the brain, often in the amygdala (a component of the limbic system that makes and receives connections with the cortex, thalamus, and other limbic structures, including the hippocampus).
  • 36. Epilepsy & Neural Plasticity  At the beginning, weak electrical stimulation, in the form of a low-amplitude train of electrical pulses, has no discernible effect on the animal’s behavior or on the pattern of electrical activity in the brain (laboratory rats or mice have typically been used for such studies).
  • 37. Epilepsy & Neural Plasticity  As this weak stimulation is repeated once a day for several weeks, it begins to produce behavioral and electrical indications of seizures.  By the end of the experiment, the same weak stimulus that initially had no effect now causes full-blown seizures.
  • 38. Epilepsy & Neural Plasticity  This phenomenon is essentially permanent; even after an interval of a year, the same weak stimulus will again trigger a seizure.  Thus, repetitive weak activation produces long-lasting changes in the excitability of the brain that time cannot reverse.  The word kindling is therefore quite appropriate: A single match can start a devastating fire.
  • 39. Epilepsy & Neural Plasticity  The changes in the electrical patterns of brain activity detected in kindled animals resemble those in human epilepsy.  The behavioral manifestations of epileptic seizures in human patients range from mild twitching of an extremity to loss of consciousness and uncontrollable convulsions.
  • 40. The short-term forms of plasticity  Synaptic plasticity mechanisms occur on time scales ranging from milliseconds to days, weeks, or longer. The short-term forms of plasticity—those lasting for minutes or less
  • 41. The short-term forms of plasticity  Facilitation of the EPP occurs at the beginning of the stimulus train and is followed by depression of the EPP.  After the train of stimuli ends, EPPs are larger than before the train.  This phenomenon is called post-tetanic potentiation.
  • 42. The Long-term forms of plasticity  Some patterns of synaptic activity in the CNS produce a long-lasting increase in synaptic strength known as long-term potentiation (LTP) , whereas other patterns of activity produce a long-lasting decrease in synaptic strength, known as long-term depression (LTD) .
  • 43. The Long-term forms of plasticity  LTP and LTD are broad terms that describe only the direction of change in synaptic efficacy; in fact, different cellular and molecular mechanisms can be involved in producing LTP or LTD at different synapses.
  • 44. The Long-term Potentiation of Hippocampal Synapses  The arrangement of neurons allows the hippocampus to be sectioned such that most of the relevant circuitry is left intact.  In such preparations, the cell bodies of the pyramidal neurons lie in a single densely packed layer that is readily apparent in the next figure.
  • 45. The Long-term Potentiation of Hippocampal Synapses  This layer is divided into several distinct regions, the major ones being CA1 and CA3.  “CA” refers to cornu Ammon , the Latin for Ammon’s horn—the ram’s horn that resembles the shape of the hippocampus.
  • 46. The Long-term Potentiation of Hippocampal Synapses
  • 47. The Long-term Potentiation of Hippocampal Synapses  The dendrites of pyramidal cells in the CA1 region form a thick band (the stratum radiatum), where they receive synapses from Schaffer collaterals, the axons of pyramidal cells in the CA3 region.
  • 48. The Long-term forms of plasticity  Electrical stimulation of Schaffer collaterals generates excitatory postsynaptic potentials (EPSPs) in the postsynaptic CA1 cells .  If the Schaffer collaterals are stimulated only two or three times per minute, the size of the evoked EPSP in the CA1 neurons remains constant.
  • 49. The Long-term forms of plasticity  However, a brief, high-frequency train of stimuli to the same axons causes LTP, which is evident as a long-lasting increase in EPSP amplitude .  LTP occurs not only at the excitatory synapses of the hippocampus shown, but at many other synapses in a variety of brain regions, including the cortex, amygdala, and cerebellum.
  • 50. The Long-term forms of plasticity
  • 51. Characteristics of LTP  First, LTP is state-dependent : The state of the membrane potential of the postsynaptic cell determines whether or not LTP occurs ( next figure ).
  • 52. Characteristics of LTP If a single weak stimulus to the Schaffer collaterals—paired with strong depolarization of the postsynaptic CA1 cell, the activated Schaffer collateral synapses undergo LTP. The increase occurs only if the paired activities of the presynaptic and postsynaptic cells are tightly linked in time, 
  • 54. Characteristics of LTP  LTP also exhibits the property of input specificity : When LTP is induced by the stimulation of one synapse, it does not occur in other, inactive synapses that contact the same neuron . Thus, LTP is restricted to activated synapses rather than to all of the synapses on a given cell
  • 55. Characteristics of LTP  Another important property of LTP is associativity : As noted, weak stimulation of a pathway will not by itself trigger LTP. However, if one pathway is weakly activated at the same time that a neighboring pathway onto the same cell is strongly activated, both synaptic pathways undergo LTP.
  • 56. Molecular mechanism of LTP  NMDA receptor channel is permeable to Ca 2+ , but is blocked by physiological concentrations of Mg 2+ .  This property provides a critical insight into how LTP is induced.
  • 57. Molecular mechanism of LTP  During low-frequency synaptic transmission, glutamate released by the Schaffer collaterals binds to both NMDA- type and AMPA/kainate-type glutamate receptors.
  • 58. Molecular mechanism of LTP  While both types of receptors bind glutamate, if the postsynaptic neuron is at its normal resting membrane potential, the NMDA channels will be blocked by Mg 2+ ions and no current will flow (Left of next figure).
  • 59. Molecular mechanism of LTP  Because blockade of the NMDA channel by Mg 2+ is voltage-dependent, the function of the synapse changes markedly when the postsynaptic cell is depolarized. Thus, conditions that induce LTP, such as high-frequency stimulation will cause a prolonged depolarization that results in Mg 2+ being expelled from the NMDA channel (Right of next figure).
  • 61. Molecular mechanism of LTP  Removal of Mg 2+ allows Ca 2+ to enter the postsynaptic neuron and the resulting increase in Ca 2+ concentration within the dendritic spines of the postsynaptic cell turns out to be the trigger for LTP.
  • 62. Molecular mechanism of LTP  The NMDA receptor thus behaves like a molecular “ and ” gate: The channel opens (to induce LTP) only when glutamate is bound to it and the postsynaptic cell is depolarized to relieve the Mg 2+ block of the receptor.  Thus, the NMDA receptor can detect the coincidence of two events
  • 63. Molecular mechanism of LTP  These properties of the NMDA receptor can account for many of the characteristics of LTP.  The specificity of LTP can be explained by the fact that NMDA channels will be opened only at synaptic inputs that are active and releasing glutamate, thereby confining LTP to these sites.
  • 64. Molecular mechanism of LTP  With respect to associativity a weakly stimulated input releases glutamate, but cannot sufficiently depolarize the postsynaptic cell to relieve the Mg 2+ block.  If neighboring inputs are strongly stimulated, however, they provide the “associative” depolarization necessary to relieve the block.
  • 65. Molecular mechanism of LTP  Rise in the concentration of Ca 2+ in the postsynaptic CA1 neuron, due to Ca 2+ ions entering through NMDA receptors, serves as a second messenger signal that induces LTP.  Cuz injection of Ca 2+ chelators blocks LTP induction, whereas elevation of Ca 2+ levels in postsynaptic neurons potentiates synaptic transmission.
  • 66. Molecular mechanism of LTP  Ca 2+ induces LTP by activating complicated signal transduction cascades that include protein kinases in the postsynaptic neuron.  At least two Ca 2+-activated protein kinases have been implicated in LTP induction Ca 2+ /calmodulin-dependent p rotein kinase (CaMKII) and protein kinase C .
  • 67. Molecular mechanism of LTP  CaMKII seems to play an especially important role: This enzyme is the most abundant postsynaptic protein at Schaffer collateral synapses, and pharmacological inhibition or genetic deletion of CaMKII prevents LTP.  The downstream targets of these kinases are not yet fully known, but apparently include the AMPA class of glutamate
  • 68. Mechanisms underlying LTP. During glutamate release, the NMDA channel opens only if the postsynaptic cell is sufficiently depolarized. The Ca 2+ ions that enter the cell through the channel activate postsynaptic protein kinases. These kinases may act in postsynaptic neurons to insert new AMPA receptors into the postsynaptic spine, thereby increasing the sensitivity to glutamate
  • 69. Molecular mechanism of LTP  LTP arises from changes in the sensitivity of the postsynaptic cell to glutamate by adding new AMPA receptors to “silent” synapses that did not previously have postsynaptic AMPA receptors.  Such rapid insertion of new AMPA receptors also can occur at “non-silent” excitatory synapses.
  • 70. LTD  If synapses simply continued to increase in strength as a result of LTP, eventually they would reach some level of maximum efficacy, making it difficult to encode new information. Thus, to make synaptic strengthening useful, other processes must selectively weaken specific sets of synapses.
  • 71. LTD  Long-term depression (LTD) is such a process.  Whereas LTP at these synapses requires brief, high-frequency stimulation, LTD occurs when the Schaffer collaterals are stimulated at a low rate—about 1 Hz—for long periods (10–15 minutes).
  • 72. LTD
  • 73. LTD  This pattern of activity depresses the EPSP for several hours and, like LTP, is specific to the activated synapses  Moreover, LTD can erase the increase in EPSP size due to LTP, and, conversely, LTP can erase the decrease in EPSP size due to LTD.
  • 74. LTD  LTP and LTD at the Schaffer collateral- CA1 synapses actually share several key elements. Both require activation of NMDA-type glutamate receptors and the resulting entry of Ca 2+ into the postsynaptic cell.
  • 75. LTD The major determinant of whether LTP or LTD arises appears to be the amount of Ca 2+ in the postsynaptic cell: Small rises in Ca 2+ lead to depression, whereas large increases trigger potentiation.
  • 76. LTD LTD, appears to result from activation of Ca 2+-dependent phosphatases that cleave phosphate groups from these target molecules . Just as LTP at this synapse is associated with insertion of AMPA receptors, LTD is often associated with a loss of synaptic AMPA receptors.
  • 77. LTD This loss probably arises from internalization of AMPA receptors into the postsynaptic cell, due to the same sort of clathrin dependent endocytosis mechanisms important for synaptic vesicle recycling in the presynaptic terminal .
  • 78. LTD
  • 79. Glutamatergic Ion Channels Alterations postulated in epilepsy
  • 80. Alterations 1- Inherited predisposition for fast or long- lasting activation of NMDA channels that alters their seizure threshold. 2- Other possible alterations include the ability of intracellular proteins to buffer calcium, increasing the vulnerability of neurons to any kind of injury that otherwise would not result in neuronal death.
  • 81. “GluR2 hypothesis” whereby preferential removal of GluR2 (with no changes in GluR1) can lead to AMPA- type glutamate receptors that flux calcium.
  • 82. Alterations It has now been shown that AMPA-type glutamate receptors can not only participate in calcium-dependent plasticity, but can also, as a result of plasticity, alter their subunit composition . It has been known that GluR2-lacking receptors flux calcium, allowing for this to occur. Either downregulation of GluR2 or upregulation of GluR1 would potentially
  • 83. Alterations It has been known that GluR2-lacking receptors flux calcium, allowing for this to occur, either: A- down regulation of GluR2 or, B- up regulation of GluR1. would potentially lead to more homomeric, calcium-permeable GluRs.
  • 85. PATHOPHYSIOLOGY The release of GABA from the interneuron terminal inhibits the postsynaptic neuron by means of 2 mechanisms: (1) direct induction of an inhibitory postsynaptic potential (IPSP), which a GABA-A chloride current typically mediates, and
  • 86. PATHOPHYSIOLOGY (2) indirect inhibition of the release of excitatory neurotransmitter in the presynaptic afferent projection, typically with a GABA-B potassium current. Alterations or mutations in the different chloride or potassium channel subunits or in the molecules that regulate their function may affect the seizure threshold or the propensity for recurrent seizures.
  • 87. PATHOPHYSIOLOGY  Properties of the chloride channels associated with the GABA-A receptor are often clinically modulated by using benzodiazepines (eg, diazepam, lorazepam, clonazepam), barbiturates (eg, phenobarbital, pentobarbital), or topiramate.
  • 88. PATHOPHYSIOLOGY  Benzodiazepines increase the frequency of openings of chloride channels, whereas barbiturates increase the duration of openings of these channels. Topiramate also increases the frequency of channel openings, but it binds to a site different from the benzodiazepine-receptor site.
  • 89. Defective GABA-A inhibition  Some epilepsies may involve mutations or lack of expression of the different GABA- A receptor complex subunits, the molecules that govern their assembly, or the molecules that modulate their electrical properties.
  • 90.  For example, hippocampal pyramidal neurons may not be able to assemble alpha 5 beta 3 gamma 3 receptors because of deletion of chromosome 15 (ie, Angelman syndrome).
  • 91. Defective activation of GABA neurons
  • 92. Feedforward Inhibition  GABAergic cells receive a collateral projection from the main afferent projection that activates the CA1 neurons, namely, the Schaffer collateral axons from the CA3 pyramidal neurons.
  • 93. Feedforward Inhibition  This feedforward projection activates the soma of GABAergic neurons before or simultaneously with activation of the apical dendrites of the CA1 pyramidal neurons.
  • 94. Feedforward Inhibition  The results in an IPSP on the soma or axon hillock of the CA1 pyramidal neurons almost simultaneously with the EPSP from the apical dendrites to the axon hillock, thus primes the inhibitory system in a manner that allows it to inhibit, in a timely fashion, the pyramidal cell's depolarization and firing of an action potential.
  • 95. Alteration  Synaptic reorganization is a form of brain plasticity induced by neuronal loss, perhaps triggered by the loss of the synaptic connections of the dying neuron, a process called deafferentation.
  • 96. Alteration  Formation of new sprouted circuits includes excitatory and inhibitory cells, and both forms of sprouting have been demonstrated in many animal models of focal-onset epilepsy and in humans with intractable temporal-lobe epilepsy.
  • 97. Alteration  Most of the initial attempts of hippocampal sprouting are likely to be attempts to restore inhibition. As the epilepsy progresses, however, the overwhelming number of sprouted synaptic contacts occurs with excitatory targets, creating recurrent excitatory circuitries that permanently alter the balance between excitatory and inhibitory tone in the hippocampal network.
  • 98. Pathophysiology Generalized Seizures  The best-understood example of the pathophysiologic mechanisms of generalized seizures is the thalamocortical interaction that may underlie typical absence seizures.
  • 99. Pathophysiology Generalized Seizures  The thalamocortical circuit has normal oscillatory rhythms, with periods of relatively increased excitation and periods of relatively increased inhibition.  It generates the oscillations observed in sleep spindles.
  • 100. Pathophysiology Generalized Seizures The thalamocortical circuitry includes: The pyramidal neurons of the neocortex. The thalamic relay neurons . The neurons in the nucleus reticularis of the thalamus (NRT).
  • 101. Thalamic Relay Neurons  Receive ascending inputs from the spinal cord and project to the neocortical pyramidal neurons. Cholinergic pathways from the forebrain and the ascending serotonergic, noradrenergic, and cholinergic brainstem pathways prominently regulate this circuitry.
  • 102. Thalamic Relay Neurons  They can have oscillations in the resting membrane potential, which increases the probability of synchronous activation of the neocortical pyramidal neuron during depolarization and which significantly lowers the probability of neocortical activation during relative hyperpolarization.
  • 103. Thalamic Relay Neurons  The key to these oscillations is the transient low-threshold calcium channel, also known as T-calcium current.  Inhibitory inputs from the NRT control the activity of thalamic relay neurons.
  • 104. T-calcium current  Have 3 functional states: open, closed, and inactivated.  Calcium enters the cells when the T- calcium channels are open. Immediately after closing, the channel cannot open again until it reaches a state of inactivation.
  • 105. T-calcium current  The thalamic relay neurons have GABA-B receptors in the cell body and receive tonic activation by GABA released from the NRT projection.  The result is a hyperpolarization that switches the T-calcium channels away from the inactive state into the closed state, which is ready for activation when needed.
  • 106. T-calcium current  The switch to closed state permits the synchronous opening of a large population of the T-calcium channels every 100 milliseconds or so, creating the oscillations observed in the EEG recordings from the cerebral cortex.
  • 107. T-calcium current  Findings in several animal models of absence seizures, have demonstrated that GABA-B receptor antagonists suppress absence seizures, whereas GABA-B agonists worsen these seizures.  Anticonvulsants that prevent absence seizures, such as valproic acid and ethosuximide, suppress the T-calcium current, blocking its channels.
  • 108. Pathophysiology Generalized Seizures  A clinical problem is that some anticonvulsants that increase GABA levels (eg, tiagabine, vigabatrin) are associated with an exacerbation of absence seizures. An increased GABA level is thought to increase the degree of synchronization of the thalamocortical circuit and to enlarge the pool of T-calcium channels available for activation.
  • 109. Natural History of Seizures  At least 60% of newly diagnosed patients can expect complete seizure control.  Approximately 50% of these patients can discontinue medication.  Up to one third of premature deaths can be directly or indirectly attributable to epilepsy.
  • 110.  Mortality is significantly higher if : 1- Symptomatic epilepsy. 2- In the first 5 to 10 years after diagnosis of epilepsy 3- younger pt.
  • 111. Natural History of Seizures  Major contributors to death in patients with epilepsy are : 1- Neoplasia. 2- Cerebrovascular disorders. 3- Pneumonia in elderly or institutionalized patients.
  • 112. Natural History of Seizures
  • 113. Natural History of Seizures  SUDEP is the most important cause of epilepsy-related deaths, particularly in the young, and people with frequent seizures and/or suboptimal AED treatment.  Appropriate postmortem investigations should be conducted in order to accurately classify the cause of death.
  • 114. AURA  The aura, of course, is the start, not the cause, of a seizure.  The aura usually lasts seconds to minutes and immediately precedes the signs of an attack.  On occasion, auras can be long-lasting, continuous, or recurrent with short intervening breaks.
  • 115. Somatosensory  Tingling, numbness, and an electrical feeling are common, whereas absence of sensation or a sensation of movement is less.
  • 116. Cephalic  Ill-defined sensations felt within the head, such as dizziness, electrical shock, tingling, fullness, or pressure.  No specific site, and related to an alteration of circulation.
  • 117. Psychical  “certain psychical states during the onset of epileptic seizures” that included “intellectual aura … dreamy feelings ... dreams mixing up with present thoughts ... double consciousness ... ‘as if I went back to all that occurred in my childhood’.  psychic auras can occur with focal seizures from anywhere in the brain
  • 118. Visual  Spots, stars, blobs, bars, or circles of light, monochromatic or variously colored, implicate seizure activity in the visual areas of the occipital lobes
  • 119. Auditory  ringing, booming, buzzing, chirping, or machinelike .  A lateralized sound is usually contralateral to the side of stimulation. At other times, partial deafness may occur.  Auras with such unformed auditory hallucinations suggest seizure activity in the superior temporal neocortex
  • 120. Olfactory  The smell of an olfactory aura is often unpleasant or disagreeable.  Other than the medial temporal lobe, the olfactory bulb is the only structure that can produce an olfactory sensation on electrical stimulation.
  • 121. Vertiginous  Stimulation of the superior temporal gyrus can elicit feelings of displacement or movement, including rotatory sensations
  • 122. Others  Gustatory  Sexual  Autonomic  Emotional
  • 124.
  • 125. Generalized Onset A) seizures with tonic–clonic manifestations I) Clonic seizures: clonic seizures are fast rhythmic events (1–2 Hz), often associated with impaired consciousness.
  • 126. Generalized Onset A) seizures with tonic–clonic manifestations II) Tonic seizures: the mechanism of tonic seizures is probably not the same as that of the tonic phase of generalized tonic– clonic seizures. Generalized tonic seizures typically occur in Lennox–Gastaut syndrome and occasionally in epilepsy with myoclonic astatic (or myoclonic-atonic) seizures.
  • 127. Generalized Onset A) seizures with tonic–clonic manifestations III) Generalized tonic–clonic seizures (GTCSs) have sudden onset with immediate loss of consciousness.
  • 128. Generalized Onset A) seizures with tonic–clonic manifestations  There is a brief tonic phase (10–30 seconds) with whole body tonic contraction, associated with a loud scream and vegetative symptoms such as tachycardia, mydriasis, increased blood pressure, and apnoea.
  • 129. Generalized Onset A) seizures with tonic–clonic manifestations  Tongue biting if present, is produced at this stage.  The clonic phase lasts around 30 seconds — 1 minute and is characterized by bilateral clonic jerks that gradually decrease in intensity and frequency.
  • 130. Generalized Onset A) seizures with tonic–clonic manifestations  The postictal phase, which can last for several minutes up to hours, is characterized by initial mydriasis, body relaxation, hypotonia, and sleep.  Urination if present, takes place at this stage.  Finally the patient gradually recovers and appears confused, presenting sometimes with automatisms, headache, and muscle
  • 131. Generalized Onset B) Myoclonic seizures  Myoclonic seizures are manifested as brief symmetrical muscular jerks of variable intensity.  Proximal muscles such as girdle muscles are mostly involved.  During stronger attacks, there is possibility of the patient falling over, but quickly recovering.
  • 132. Generalized Onset B) Myoclonic seizures  The patient is usually conscious during the jerks. Myoclonic seizures may often be triggered by photic stimulation.
  • 133. Generalized Onset C) Absences  Typical absence seizures are brief (5–12 seconds).  They appear mostly in children and are clinically characterized by sudden interruption of ongoing activity and staring straight ahead or drifting upwards.  There is complete loss of awareness during the seizure.
  • 134. Generalized Onset C) Absences  The onset and offset is sharp.  Absence seizures can be easily produced if the child is asked to hyperventilate.  Concomitant EEG abnormalities are typical generalized spike-and wave discharge at 3 Hz.
  • 135. Generalized Onset C) Absences  Possible associated manifestations include slight rhythmic (3 Hz) eyelid myoclonus, slight decrement or increment of muscle tone, simple gestural automatisms (if the absence is of long duration), and, rarely, vegetative symptoms (urinary incontinence, pupil dilatation, pallor, flushing, tachycardia, change in blood pressure).
  • 136. Generalized Onset D) Epileptic spasms  These consist of a brief (0.5–2 second) tonic contraction of the neck and trunk in flexion, extension or in a mixed flexed- extended posture.  They occur most commonly in clusters upon awakening. 
  • 137. Generalized Onset D) Epileptic spasms  Each cluster consists of several spasms the intensity and frequency of which follow an increasing-plateau-decreasing pattern.  Therefore the first spasms in a cluster can be barely visible, presenting a forced opening of the eyes or slight nodding of the head.
  • 138. Generalized Onset D) Epileptic spasms  Ictal EEG is characterized by pseudo- periodic slow polyphasic EEG discharges that are concomitant to spasms.  EEG activity related to spasms can also be a bilateral electrodecremental pattern.  Electromyographic activity from deltoid and neck muscles shows a characteristic rhomboid pattern during the spasm, usually lasting 0.5–2 seconds
  • 139. Generalized Onset E) Atonic seizures  Atonic seizures are characterized by decrease or complete inhibition of postural tone.  They manifest as head nodding, dropping of the jaw or of a limb, or falls.
  • 140. Generalized Onset E) Atonic seizures  The patient can then lie motionless on the ground or promptly resume the posture. Pure atonic seizures are rare.  Ictal EEG is usually characterized by a generalized slow spike-and-wave discharge.
  • 141. Focal Onset A) Focal sensory seizures. I) With elementary sensory (visual, somatosensory, vestibular, olfactory, gustatory, or auditory) symptoms as produced by activation of primary sensory cortices (e.g. occipital and parietal lobe seizures).
  • 142. Focal Onset A) Focal sensory seizures. II) With experiential symptoms. These are complex, formed, distorted and/or multimodal sensory symptoms, usually implying seizure initiation in association cortices, such as the temporo-parieto- occipital junction.  B) Focal motor seizures. I) With elementary clonic motor signs. II) With asymmetric tonic motor seizures (e.g.
  • 143. Focal Onset B) Focal motor seizures. I) With elementary clonic motor signs. II) With asymmetric tonic motor seizures (e.g. supplementary motor seizures). III) With typical (temporal lobe) automatisms (e.g. mesial temporal lobe seizures). IV) With hyperkinetic automatisms. V) With focal negative myoclonus. VI) With inhibitory motor seizures.
  • 144. Lobar epilepsy Temporal lobe  Automatisms—complex motor phenomena, but with impaired awareness and no recollection afterwards, varying from primitive oral (lip smacking, chewing, swallowing) or manual (fumbling, fiddling, grabbing) movements, to complex actions (singing, kissing, driving a car and violent acts) •
  • 145. Lobar epilepsy Temporal lobe  Abdominal rising sensation or pain (± ictal vomiting; or rarely episodic fevers.  Dysphasia (ictal or post-ictal)  Memory phenomena—déjà vu (when everything seems strangely familiar), or jamais vu (everything seems strangely unfamiliar)
  • 146. Lobar epilepsy Temporal lobe  Hippocampal involvement may cause emotional disturbance, eg sudden terror, panic, anger or elation, and derealization (out-of-body experiences), which in combination may manifest as excessive religiosity.
  • 147. Lobar epilepsy Temporal lobe  Uncal involvement may cause hallucinations of smell or taste and a dreamlike state, and seizures in auditory cortex may cause complex auditory hallucinations, eg music or conversations.  Delusional behaviour;
  • 148. Lobar epilepsy Temporal lobe  Finally, you may find yourself not believing your patient’s bizarre story—eg “Canned music at Tesco’s always makes me cry and then pass out, unless I wear an earplug in one ear” or “I get orgasms when I brush my teeth” (right temporal lobe hyper- and hypo perfusion, respectively).
  • 149. Frontal lobe  Motor features such as posturing, movements of the head and eyes,or peddling movements of the legs  Jacksonian march (a spreading focal motor seizure with retained awareness, often starting with the face or a thumb)  Motor arrest
  • 150. Frontal lobe  Subtle behavioural disturbances (often diagnosed as psychogenic)  Dysphasia or speech arrest  Post-ictal Todd’s palsy
  • 151. Parietal lobe  Sensory disturbances—tingling, numbness, pain (rare)  Motor symptoms (due to spread to the pre- central gyrus).
  • 152. Occipital lobe  Visual phenomena such as spots, lines, flashes.
  • 153. Classification of The Epilepsies And of Epilepsy Syndrome
  • 154. Partial & Generalized  In 1981 the International League Against Epilepsy (ILAE) Commission on Classification and Terminology proposed an International Classification of Epileptic Seizures .  Seizures were classified as partial and generalized (Next table) .
  • 155.
  • 156. Partial & Generalized  Seizures were defined as partial if the first clinical and electroencephalographic (EEG) signs indicated that initial activation was limited to part of one cerebral hemisphere.  Partial seizures were classified in simple or complex on the basis of whether or not awareness was impaired during the attack.
  • 157. Partial & Generalized  Seizures were considered as generalized if the first clinical and EEG changes indicated the initial involvement of both hemispheres.
  • 158. Syndromic Classification  The Commission adopted a syndromic classification.  A syndrome was considered as a group of signs and symptoms customarily occurring in association, including seizure types, clinical background, neurophysiological and neuroimaging findings and, often, outcome (Next table ) .
  • 159.
  • 160. Syndromic Classification  According to symptoms, epilepsies were classified as generalized and partial (or focal).  Generalized epilepsies were defined as characterized by generalized seizures, bilateral motor manifestations, and generalized interictal and ictal EEG discharges.
  • 161. Syndromic Classification  Partial epilepsies were those characterized by seizures originating from a circumscribed brain region, and by clinical manifestations consistent with a focal onset of the epileptic discharge, with or without subsequent spread, and by focal ictal or interictal EEG abnormalities.
  • 162. Idiopathic VS Symptomatic  The 1989 Classification also divided the epilepsies by aetiology, into two broad categories: idiopathic and symptomatic epilepsies.
  • 163. Idiopathic VS Symptomatic  Idiopathic epilepsies were defined by absence of any brain lesions, normal background EEG activity and interictal generalized spike and wave discharges. They were considered to be due to a genetic predisposition or to a specific mode of inheritance.
  • 164. Idiopathic VS Symptomatic  Symptomatic epilepsies were considered the expression of a focal or diffuse brain lesion as demonstrated by clinical history, structural neuroimaging, EEG findings, or biological tests.
  • 166. B. UNCLASSIFIED SEIZURES i. Neonatal seizures ii. Infantile spasms
  • 167. Neonatal Seizure  Less than 1 month of age.  Brief episodes of apnea, eye deviation, eye blinking, or repetitive movements of the arms and legs.
  • 168. Infantile Spasms  Infants under 12 months.  Abrupt movements of the head, trunk, or limbs.  The classic spasm is a sudden flexion of the neck and abdomen with extension of the limbs.
  • 169.
  • 170.
  • 172.
  • 173.
  • 174.
  • 175.
  • 176.
  • 177. Ultimately, the rationale for diagnostic studies is to provide the patien with effective therapy. The goals of therapy are no seizures, no side effects, and no lifestyle limitations.
  • 178. General Considerations  The initial diagnostic approach to the patient with epilepsy and related episodic disorders has importance for both long- term prognosis and treatment, including the determination of: 1- whether treatment is necessary 2- The type(s) of therapy to be considered.
  • 179. General Considerations  When evaluating a patient with possible epilepsy, the basic approach is as follows: Is this epilepsy, and, if so, is it focal or generalized, Any triggers?  Once a seizure is determined to be a manifestation of epilepsy, a diagnostic workup must be performed to understand the underlying cause(s) and epilepsy syndrome type when possible
  • 180. Essential for the diagnosis 1) Recurrent seizures. 2) Characteristic electroencephalographic changes accompany seizures. 3) Mental status abnormalities or focal neurologic symptoms may persist for hours postictally.
  • 181. First Seizure In assessing a first-ever seizure, consider also: 1- Is it really the first? Ask the family and patient about past funny turns/odd behaviour. 2- Déjà vu and odd episodic feelings of fear may well be relevant.
  • 182. First Seizure 3- Was the seizure provoked? Provoked 1st seizures are less likely to recur (3–10%, unless the cause is irreversible, eg an infarct or glioma); if it was unprovoked, recurrence rates are 30–50%.
  • 183. First Seizure provocations are different to triggers: most people would have a seizure given sufficient provocation, but most people do not have seizures however many triggers they are exposed to, so triggered seizures suggest epilepsy.
  • 184. First Seizure Triggered attacks tend to recur. Admit to substantiate ideas of pseudoseizures, or for recurrent seizures.
  • 185. Laboratory studies  Electrolytes  Glucose  Ca  Mg  Liver and renal function test  Urianalysis  Toxicology screen  Lumbar puncture
  • 186. EEG Clinical Applications 1- Diagnosis of epilepsy. 2- Selection of AED therapy. 3- Evaluation of response to treatment. 4- Determination of candidacy for drug withdrawal. 5- Surgical localization.
  • 187. EEG  An EEG cannot exclude or refute epilepsy; it forms part of the context for diagnosis, so don’t do one if simple syncope is the likely diagnosis (often false +ve).
  • 188. EEG  In 1st unprovoked fits, unequivocal epileptiform activity on EEG helps assess risk of recurrence, based on studies in both adults and children, with recurrence rates that range from 30% to 70% in the first year.
  • 189.  Therefore, when the EEG shows an epileptiform discharge after a single seizure, treatment may be considered even before a diagnosis of epilepsy is established.  Only do emergency EEGS if non- convulsive status is the problem .
  • 190. EEG  Epileptiform abnormalities usually appear as spikes, sharp waves, or spike-wave discharges that are distinct from the normal background activity and indicate an increased seizure tendency.
  • 191.  The spike discharges are predominantly negative transients with steep ascending and descending limbs and a duration of 20 ms to 70 ms.  A sharp wave is a broader potential with a duration of 70 ms to 200 ms.
  • 192.
  • 193. Sensitivity & Specificity  The sensitivity of a single EEG study to record an epileptiform abnormality may be 50% or less in people with epilepsy so normal interictal EEG studies do not exclude the presence of a seizure disorder.  The diagnostic yield increases to 80% to 90% if three or more serial EEGs are performed.
  • 194. EEG  Ultimately, epilepsy is a clinical diagnosis and the EEG serves to provide supporting evidence; in other words, you treat the patient and not the EEG.
  • 195. The presence of an epileptiform abnormality does not always indicate a seizure disorder  Interictal epileptiform discharges are seen rarely in adults or children without epilepsy (0.2% to 3%).  Healthy airline personnel who underwent EEG studies.  Occipital spikes have been observed in blind people.
  • 196. The presence of an epileptiform abnormality does not always indicate a seizure disorder  Generalized spikes have been reported in relatives of patients with genetic generalized epilepsies.  Interictal epileptiform discharges may also be seen in patients receiving bupropion, cefepime, clozapine, lithium, and tramadol, and in pt with renal failure or an acute encephalopathy.
  • 197. Factors That May Affect The Diagnostic Yield of EEG (1) The age of the patient (2) Seizure classification and epileptic syndrome diagnosis (3) Presence of AED therapy (4) Proximity of the EEG recording to seizure activity (since patients with more recent seizures more frequently have diagnostic EEG recordings).
  • 198. Indications for video-EEG  Evaluation of spells.  Seizure classification.  Seizure quantification.  Assessment of seizure precipitating factors.  Surgical localization in drug-resistant focal epilepsy.
  • 199. MRI  Is the structural neuroimaging procedure of choice in people with epilepsy.  All individuals with seizures should undergo an MRI study unless the patient has a confirmed genetic generalized epilepsy syndrome (eg, childhood absence epilepsy) or a contraindication exists that does not permit this imaging procedure to be done safely
  • 200. MRI Help In  Identification of the pathologic findings associated with focal or generalized seizures.  Localization of the epileptogenic zone.  Determination of surgical localization in drug-resistant focal epilepsy
  • 202. The basic goals of treatment for epilepsy are to: 1- Help the patient achieve freedom from further seizures without adverse effects of therapies. 2- Minimize the frequency of disabling or potentially injurious seizure types when seizure freedom is not achieved.
  • 203. 3- Address any relevant interictal comorbidities of epilepsy to maximize quality of life for people with epilepsy.
  • 204. Starting treatment  Single seizures: No treatment unless there is a high risk of recurrence, e.g. abnormal EEG as in JME or an abnormal MRI. If precipitating factors (e.g. alcohol) identified, avoidance may prevent recurrence
  • 205. Starting treatment  After a single unprovoked seizure, risk of recurrence is 24% with no cause and normal EEG. and 65% if associated with a neurological abnormality + abnormal EEG.
  • 206. Starting treatment  Prophylaxis : No indication for starting treatment in patients with head injuries, craniotomy, brain tumours, unless seizures occur.
  • 207.  Drug treatment Aim of treatment is to render patient seizure-free with minimal side-effects.  Other factors include sudden unexpected death in epilepsy (SUDEP)— 1/200/year in refractory epilepsy. –
  • 208.  Factors to be taken into account: - age; - sex; - type of epilepsy; - other drugs, e.g. contraceptive pill; - other medical conditions, e.g. liver or renal dysfunction.
  • 209.  Treatment is initiated at low dose gradually titrating to an effective level to avoid side- effects (‘start low, go slow’). - If seizures continue, increase dose to maximum tolerated. - If seizures continue, withdraw first drug and try another first-line drug. - If unsuccessful, adjunctive treatment with a second-line drug should be considered.
  • 210.
  • 211.
  • 212. Surgery  Should be considered, and patients referred to a specialist centr, in cases with: - Surgically resectable lesion. - Temporal lobe seizures in whom there is evidence of mesial temporal sclerosis - In such patients seizure-free rates 80%, with 3–4% permanent neurological deficit and 1% mortality rates.
  • 213. Vagus nerve stimulation  is an option with no serious side-effects in those with refractory epilepsy, and unsuitable for surgery.
  • 214. Counselling After any ‘fit’ Advise about dangers (eg swimming, driving, heights) until the diagnosis is known; then give individualized counselling on employment, sport, insurance and conception . Avoid driving until seizure free for >1yr.